Bisphenol A triggers activation of ocular immune system and aggravates allergic airway inflammation

Tatsuo Ueda,Takumi Adachi,Tomoya Hayashi,Koubun Yasuda,Kazufumi Matsushita,Eiko Koike,Rie Yanagisawa,Takahiro Nagatake,Jun Kunisawa,Ken J Ishii,Kenzo Tsuzuki,Etsushi Kuroda
DOI: https://doi.org/10.1016/j.clim.2024.110370
Abstract:Bisphenol A (BPA) is widely used in manufacturing plastic products, and it has been reported that exposure through the airway or orally aggravates allergic airway inflammation. Because BPA is detected in the atmosphere and indoor environments, the eyes can also be exposed to BPA. After ocular exposure to BPA and antigen via eye drops, we observed enhanced antigen uptake of antigen-presenting cells (APCs) in tear duct-associated lymphoid tissue (TALT). Additionally, we observed the formation of germinal center (GC) B cells in TALT and induction of allergic airway inflammation in mice sensitized with BPA and antigen via eye drops, followed by airway antigen exposure. We also found that DNAX-activating protein of 12 kDa (DAP12)-deficient mice displayed impaired activation of APCs enhanced by ocular exposure to BPA. These results indicate that ocular sensitization to BPA and allergen triggers allergic inflammation via TALT activation, and that DAP12 might be a key molecule for modulating the ocular immune system.
What problem does this paper attempt to address?